8-K current report · filed Nov 18, 2026

TuHURA Biosciences, Inc./NV (HURA) 8-K Current Report: November 18, 2026

Item 2.03HURA overview

Short answer

TuHURA Biosciences, Inc./NV (HURA) filed an 8-K current report with the SEC on November 18, 2026 reporting Item 2.03 (Creation of a Direct Financial Obligation). $1.3 million borrowed through two $650,000 draws on the revolving credit facility.

TuHURA Biosciences, Inc./NV 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.03 · Creation of a Direct Financial Obligation

  • $1.3 million borrowed through two $650,000 draws on the revolving credit facility
  • Borrowings intended for general corporate purposes, increasing near-term liquidity
  • Facility maximum availability $50 million, with maturity on April 21, 2031
  • Additional debt creates future repayment obligations and potential financing-cost exposure

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other TuHURA Biosciences, Inc./NV 8-K filings

Get the next HURA 8-K as it lands

Follow HURA for push alerts, or ask the research agent what this filing means.